An exosome detection platform for cancer diagnosis
Liquid biopsy is a non-invasive approach for personalised cancer diagnosis and relies on circulating tumour cells and tumour DNA. However, extracellular vesicles termed exosomes are emerging as promising biomarkers for prompt cancer detection. To facilitate routine exosome analysis in the clinic, scientists of the EU-funded IMPED project propose to develop a next-generation technology capable of extracting and analysing exosomes from liquid biopsies or serum samples at the proteomic and genomic levels. The technology will be the first to combine both intra- and extra-vesicle detection on a single platform, offering important insight into precision cancer management on an individual patient basis.
Field of science
- /natural sciences/biological sciences/biochemistry/biomolecules/proteins/proteomics
- /natural sciences/physical sciences/classical mechanics/fluid mechanics/microfluidics
- /medical and health sciences/clinical medicine/cancer
Call for proposal
See other projects for this call